Terms ending in 2029
Rapid Pathogen Screening, Inc.
Every in-force patent on Rapid Pathogen Screening, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,090,670 | Use of Peptides for Promoting Wound Healing In force · High confidence | Visus Therapeutics, Inc. | In force | High confidence | |
| US 9,115,180 | Use of peptides for promoting wound healing In force · High confidence | Visus Therapeutics, Inc. | In force | High confidence | |
| US 8,962,260 | Method and Device for Combined Detection of Viral and Bacterial Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 9,372,192 | Method And Device For Combined Detection Of Viral And Bacterial Infections In force · Medium confidence | Rapid Pathogen Screening, Inc. | In force | Medium confidence | |
| US 10,808,287 | Improved Methods and Devices for Accurate Diagnosis of Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 9,121,849 | Lateral Flow Assays In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Rapid Pathogen Screening, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.